Hu Y - Search Results

1

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment.

Qiu Y, Liao P, Wang H, Chen J, Hu Y, Hu R, Zhang H, Li Z, Cao M, Yang Y, Li M, Xie X, Li Y. Qiu Y, et al. Among authors: hu y, hu r. Int J Biol Sci. 2023 Sep 18;19(15):4948-4966. doi: 10.7150/ijbs.86632. eCollection 2023. Int J Biol Sci. 2023. PMID: 37781520 Free PMC article.

2

A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.

Chen Y, Xie X, Wu A, Wang L, Hu Y, Zhang H, Li Y. Chen Y, et al. Among authors: hu y. J Exp Clin Cancer Res. 2018 Jan 22;37(1):12. doi: 10.1186/s13046-018-0682-x. J Exp Clin Cancer Res. 2018. PMID: 29357910 Free PMC article.

3

A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity.

Xie X, Zhou W, Hu Y, Chen Y, Zhang H, Li Y. Xie X, et al. Among authors: hu y. Cell Death Dis. 2018 Mar 7;9(3):379. doi: 10.1038/s41419-018-0420-5. Cell Death Dis. 2018. PMID: 29515106 Free PMC article.

4

Lenalidomide Augments the Antitumor Activities of Eps8 Peptide-Specific Cytotoxic T Lymphocytes against Multiple Myeloma.

Xie X, Chen Y, Hu Y, He Y, Zhang H, Li Y. Xie X, et al. Among authors: hu y. Mol Cancer Ther. 2019 Dec;18(12):2258-2269. doi: 10.1158/1535-7163.MCT-19-0424. Epub 2019 Aug 14. Mol Cancer Ther. 2019. PMID: 31413179

5

EPS8-mediated regulation of multiple myeloma cell growth and survival.

Zhang H, Zhou L, Zhou W, Xie X, Wu M, Chen Y, Hu Y, Du J, He Y, Li Y. Zhang H, et al. Among authors: hu y. Am J Cancer Res. 2019 Aug 1;9(8):1622-1634. eCollection 2019. Am J Cancer Res. 2019. PMID: 31497346 Free PMC article.

6

Dual targeting of NUAK1 and ULK1 using the multitargeted inhibitor MRT68921 exerts potent antitumor activities.

Chen Y, Xie X, Wang C, Hu Y, Zhang H, Zhang L, Tu S, He Y, Li Y. Chen Y, et al. Among authors: hu y. Cell Death Dis. 2020 Sep 1;11(8):712. doi: 10.1038/s41419-020-02885-0. Cell Death Dis. 2020. PMID: 32873786 Free PMC article.

7

Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen.

Xie X, Hu Y, Ye T, Chen Y, Zhou L, Li F, Xi X, Wang S, He Y, Gao X, Wei W, Ma G, Li Y. Xie X, et al. Among authors: hu y. Nat Biomed Eng. 2021 May;5(5):414-428. doi: 10.1038/s41551-020-00624-6. Epub 2020 Oct 12. Nat Biomed Eng. 2021. PMID: 33046865

8

Metabolic regulation of the bone marrow microenvironment in leukemia.

Xu B, Hu R, Liang Z, Chen T, Chen J, Hu Y, Jiang Y, Li Y. Xu B, et al. Among authors: hu y, hu r. Blood Rev. 2021 Jul;48:100786. doi: 10.1016/j.blre.2020.100786. Epub 2020 Dec 9. Blood Rev. 2021. PMID: 33353770 Review.

9

Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms.

Chen J, Zhang H, Zhou L, Hu Y, Li M, He Y, Li Y. Chen J, et al. Among authors: hu y. Front Oncol. 2021 Feb 3;10:584367. doi: 10.3389/fonc.2020.584367. eCollection 2020. Front Oncol. 2021. PMID: 33614478 Free PMC article. Review.

10

Author Correction: Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen.

Xie X, Hu Y, Ye T, Chen Y, Zhou L, Li F, Xi X, Wang S, He Y, Gao X, Wei W, Ma G, Li Y. Xie X, et al. Among authors: hu y. Nat Biomed Eng. 2021 May;5(5):482. doi: 10.1038/s41551-021-00726-9. Nat Biomed Eng. 2021. PMID: 33875842 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,111 results

Search Page

Filters